Showing posts with label Champix. Show all posts
Showing posts with label Champix. Show all posts

Monday, 7 November 2011

LES PROFITS DES GÉANTS PHARMACEUTIQUES SONT MENACÉS

Nous vous dirigeons vers deux articles (au bas de la page) d’un très grand intérêt, publiés dans le site http://www.unairneuf.org
Le premier rapporte les résultats d’une étude récente sur le Champix, médicament prescrit pour la cessation du tabagisme.  L’étude ( PLoS ONE: Suicidal Behavior and Depression in Smoking Cessation Treatments ) conclut que les risques pour des problèmes d’ordre psychiatrique chez les utilisateurs sont beaucoup plus élevés que pour le médicament Zyban et les produits nicotiniques qu’on trouve en vente libre dans les pharmacies.  Sans grande surprise, Pfizer dément ces allégations et conduit sa propre étude avec une date projetée pour la publication des résultats en 2017. Study Links Chantix to Suicide Risk, but FDA Disagrees

Encore cinq ans à profiter des revenus que Champix rapporte est certes très intéressant pour Pfizer, mais qu’en est-il des fumeurs à qui on continuera de prescrire ce médicament susceptible à mener jusqu’au suicide? 
     
Le deuxième article expose les craintes de l’industrie pharmaceutique en rapport avec la menace que la cigarette électronique présente pour leurs profits.  Rappelons-nous que la cigarette électronique est bannie au Canada mais est légale en France et dans la grande majorité des autres pays occidentaux  y compris les États-Unis.  Lire ici (en anglais) la correspondance de C.A.G.E. avec Santé Canada :  http://cagecanada.blogspot.com/2009/05/e-cigarettes-letter-to-health-canada.html 


Tuesday, 31 May 2011

LE CHAMPIX NE SERA PLUS REMBOURSÉ EN FRANCE !

Nous apprenons par Canoë.ca que les instances de santé françaises ont  ‘’mis leurs culottes’’ et ont annoncé qu’ils ne rembourseront plus le médicament pour le sevrage du tabagisme, le Champix.  Nous aurons préféré de lire qu’ils interdisaient sa vente totalement en raison de tous ses effets secondaires y compris le suicide, mais c’est quand même un pas dans la bonne direction qui, nous espérons, découragera les fumeurs d’y avoir recours.  Rappelons à nos lecteurs que le Dr. Michael Siegel, anti-tabagiste notoire, a déjà demandé à ce que ce médicament soit retiré du marché.   

Le mécontentement des anti-tabagistes  ne nous surprend aucunement étant donné que plusieurs entre eux entretiennent des relations incestueuses avec l’industrie pharmaceutique.  Il y en a même une anti-tabagiste britannique qui a déjà exprimé qu’il importait peu que ce médicament soit dangereux car 50% des fumeurs vont mourir des méfaits de leur tabagisme de toutes façons !  (“We are talking about a fairly unhealthy section of the population anyway . . . one in two will die because of smoking.)

Bravo à la France !  Il reste à espérer que le Canada suive.  

Célébrons la journée internationale sans tabac en motivant ceux qui désirent d’arrêter, de le faire sans médication.  Des millions l’ont fait à travers le monde avant que l’industrie pharmaceutique les prenne en otage en leur inculquant la notion qu’ils sont trop dépendants pour y arriver sans la pharmacothérapie.  


Friday, 27 May 2011

ONTARIO LUNG ASSOCIATION - CHARITY ORGANIZATION OR BIG PHARMA FRONT GROUP?


Pharma inhaler ressembling a tampon
Nicotine replacement therapy has been ever increasingly marketed aggressively since the early 90’s. Over the years, the pharmaceutical industry has been attempting to make it ever more attractive to consumers by sugar coating it and enhancing its flavor with fruit and mint essences – while at the same time they mudsling the tobacco industry for marketing attractive and kiddy friendly smokeless tobacco products.  Many nicotine replacement products such as lozenges, patches and even inhalers - poorly mimicking the act of smoking with devices ressembling tampons - are continuously peddled to the public directly by the pharmaceutical industry, pharmacists and anti-tobacco advocates. They have even succeeded to convince governments in various countries (including the province of Quebec) and private insurance companies to reimburse the cost of using nicotine replacement therapy which costs pennies to manufacture but is indecently marked up when it reaches the consumer. Pr. Robert Molimard had this to say on the cost of nicotine: ’ Nicotine presently costs, if you buy it at Fluka -- that is an international chemical product company -- 440 euros per liter. An average cigarette will deliver to you about 0,8 mg of nicotine -- since there are 1 million of 1mg in one liter – it would mean 1 200 000 cigarettes. In other words with one euro -- and you can calculate it yourself -- you would buy 143 packs of cigarettes. http://cagecanada.homestead.com/CorporateShenanigans.html

One can rightfully think that it’s all worth it if it really helps people stop smoking for good . Unfortunately this can’t be further from the truth. Reputable studies have shown that nicotine replacement therapy has very poor (as little as 1,6%) long term success rates. Such poor succes rates would not have only never been acceptable for any other type of medication but public or private insurance plans would have categorically refused covering its costs.

Yet nicotine replacement therapy gets a free, no questions asked, pass. Why? Part of the reason may reside in the fact that when it comes to the tobacco issue, Big Pharma tends to do its  lobbying and bidding through the sponsoring of associations that politicians, insurance companies and much of the public blindly trust, or at least pretend to. Who would dare question the authoritarian opinion and advice of long established charity organizations such as the cancer, the lung and heart associations?  It would be political and professional suicide and would be considered as a callous attitude if either politicians or other authoritarian entities dared to challenge their contentions.  Nicotine replacement therapy therefore remains a) heavily prescribed b) continuously reimbursed either through private or public medical insurance plans in various countries including the province of Quebec c) highly lucrative repetitive business for Big Pharma d) an un-attackable myth

The latest campaign to boost nicotine replacement therapy and the dangerous drug Champix (Chantix in the USA) and Zyban which carry a black box warning in the U.S.A., comes to us from the Ontario Lung Association.


In a recent press release that the Canadian press picked up (linked below), they are launching the ''Abolish Word Habit Program''  which is campaigning  for stopping to call smoking a habit and start calling it by what it is i.e. an addiction.

They explain how quitting smoking is harder than quitting heroin and cocaine and how nicotine is delivered to the brain in the addictive format.

Then they switch into their offensive mode of peddling nicotine replacement therapy and medication and especially their main agenda for this particular campaign:  getting public healthcare and private insurance plans to cover nicotine replacement therapy and Champix/Zyban :

‘’Seventy-nine per cent of smokers surveyed said they would be more likely to try at least one smoking cessation medication if they were free of charge.


(…) most smokers can't quit cold turkey and politicians need to step up.’’


He advocates counselling, nicotine replacement therapies and medications that people can afford through a drug plan.’’

How shameful for the Ontario Lung Association to lobby  for the squandering of public funds and especially that our public healthcare system is on the verge of becoming totally unsustainable!

Oh, just in case anyone still thinks that their motives are noble, reading the very last sentence of their press release should convince even the most skeptical of our readers:

‘’The association's 'abolish the word habit' program is being sponsored by the drug company Pfizer Canada Inc.’’

We will leave the last word on nicotine addiction to Pr. Robert Molimard’s expertise and wisdom.  Excerpt from: BELIEFS, MANIPULATION AND LIES IN THE TOBACCO ISSUE - Robert Molimard

The big fraud in the tobacco issue was none other than the publication of the 1988 Surgeon General Report entitled “Nicotine Addiction’’. This fraud is incomprehensible unless one sees the link with the launch of the nicotine gum. The major premise of the Report seems to be a syllogism that states: “Tobacco products cause a powerful addiction’’ The minor premise is: “Tobacco contains a neurotropic poison - nicotine’’. Hence follows the conclusion: “Therefore nicotine is responsible for the addictiveness of tobacco’’. But there is no evidence that allows us to draw such a conclusion. A host of other assumptions are possible, and there are even major arguments to oppose it, such as the fact that no cases of nicotine dependence have ever been documented when this substance was used in isolation, as was already established long before the “Medication Enterprises” began marketing nicotine as a form of medication.

(…)having arbitrarily decided that nicotine alone explains tobacco dependence and having it engrained in the minds of doctors, the authorities and the public, any research on the other possible factors of this dependency is now excluded in advance and a vast new market is made available for commercial exploitation by the pharmaceutical industry.

Kick the habit of calling smoking a habit, it's an addiction: lung association

Thursday, 7 April 2011

POTPOURRI


Refusing to be outdone by San Francisco for the prestigious title of Nanny Capital, New York City is considering banning fast-food toy giveawaysPerhaps Mayor Bloomberg’s next move is to force restaurants to offer only liver broccoli casserole or brussel sprout hash on the children’s menus?  

And NYC health workers are told what to eat and wear in cubicle area What’s next?  Telling them how often they should clip their toe nails and what type of toothpaste they should be using?

Le Tamiflu au coeur d'une polémique qui ne relève que des conflits d’intérêts flagrants entre l’industrie pharmaceutique et ceux qui conseillent nos élus qui sont sur le point d’investir des dizaines de millions de dollars  pour stocker un médicament que plusieurs disent avoir très peu d’effets sur les symptômes de la grippe.







In Spain, the post smoking ban heart attack miracles are now being reported before they even happen.  Closed spaces smoking ban resulting in fewer heart attacks in Spain




Avis à l’O.M.S. et à un nombre croissant d’hôpitaux et cliniques aux E.U. qui refusent d’engager des fumeurs même s’ils fument seulement en dehors de leurs heures de travail :  Le chômage augmente les risques de mourir prématurément si on en croit cette étude qui nous parvient de Montréal. 






From Springfield Missouri Springfield voters approved an indoor smoking ban by a margin of 53 percent to 47 percent.  "Clean Air Springfield raised more than $82,000 in support of the ban. Other than a handful of local cash contributions, 99 percent of the total came from the American Cancer Society, the ACS Cancer Action Network and the American Heart Association. Live Free Springfield raised a fraction of that total -- about $16,600 at last report -- and members have been quick to tout the local sources of their funding."  --- It is actually impressive that under such unequal circumstances, 47% of voters still voted against the ban. 


 

À lire dans le site unairneuf.org l’influence de Pfizer sur la politique de prévention du tabagisme.  ‘Tout bénéfice pour Big Pharma ; et pour les fumeurs ?’’




Sad news from the UK with an article about how a Father accused of killing family may have been taking anti-smoking drug which coincides with an article from Dr. Michael Siegel from Boston who is calling for the removal of Chantix/Champix from the market.  and in which he exposes the financial conflicts of interest of FDA members and argues’that both the FDA and the anti-smoking groups bear major responsibility in the tragedy of Chantix-related suicide.’’



Tuesday, 8 March 2011

PRIMUM NON NOCERE

Nous vous signalons la parution d’un récent article du Pr. Robert Molimard dans le site du groupe français le FORMINDEP, qui examine les origines, la façon qu’il agit sur les récepteurs du cerveau, l’efficacité, les effets indésirables, et les considérations éthiques quant à la continuation de la mise en marché du Champix, médicament pour le sevrage tabagique

Des centaines d’Américains et de Canadiens ont déposé des requêtes en recours collectif contre Pfizer - le fabricant - qu’ils accusent de ne pas avoir assez informé le public des risques liés à son utilisation. La FDA a ordonné que la mise en garde la plus sévère permise en vertu des règlements fédéraux (black box warning), soit apposée sur le produit. On reproche au médicament d’augmenter le risque de changements dans le comportement, la dépression, l'hostilité, les pensées suicidaires et même le suicide.

Le professeur souligne dans son article exactement ce qu’on dit depuis longtemps, à savoir que malgré que fumer peut conduire à la maladie, le tabagisme en lui-même n’est pas une maladie. En effet, nombreux sont les exemples des fumeurs qui vivent vieux et en santé pour éventuellement mourir de causes aucunement liées à leur tabagisme. Nous nous posons d’ailleurs la même question que le professeur, à savoir s’il est justifié de soumettre des gens en santé à des risques importants qui peuvent les mener jusqu’à la mort, pour hypothétiquement leur éviter des maladies futures qui ne se manifesteront que plus tard et possiblement même jamais. Et ce, non seulement sur le plan physique mais aussi sur le plan psychologique comme le Dr. Jean-Jacques Bourque nous a expliqué dans son livre ‘’Écrasons la cigarette, pas le fumeur’’.

Malgré qu’il doit y avoir plusieurs anti-fumeurs qui le pensent tout bas, Il y au moins une lobbyiste anti-tabac anglaise qui a admis publiquement qu’il n’y a pas de prix trop cher à payer pour arrêter de fumer. ‘’De toute façon, nous parlons d'une partie assez malsaine de la population . . . un sur deux va mourir à cause du tabagisme.’’ (We are talking about a fairly unhealthy section of the population anyway . . . one in two will die because of smoking.) a-t-elle déclaré sans aucune honte ni remords apparents. Cela évidemment sous-entend qu’il vaut mieux soumettre les fumeurs au risque de souffrir et même mourir immédiatement avec le Champix, que de continuer à fumer. Quel contraste avec le Pr. Molimard pour qui le ‘’primum non nocere’’ conserve encore toute sa signification. C’est tout à son honneur ! 

Champix®, le jeu en vaut-il la chandelle ?

Le fumeur n'est pas un malade

Monday, 20 December 2010

BELIEFS, MANIPULATION AND LIES IN THE TOBACCO ISSUE - Robert Molimard

English translation of the French original of this paper that was presented at a meeting of la Société d'Addictologie Francophone at the Sainte Anne Hospital in Paris on December 9, 2010, under the theme ‘’Truths, Lies and beliefs in regards to addiction’’ ("Vérités, mensonges et…croyances en addictologie’’). It will be published in the next issue of the journal ‘’Le Courrier des Addictions’’, organ of the SAF.

Translated by Iro Cyr with the assistance of Pr. Robert Molimard and Dan Romano

Disclaimer: In accordance with French law, Pr. Robert Molimard declares that he doesn’t have any competing interests with neither the pharmaceutical nor the tobacco industries.


Beliefs, manipulation and lies in the tobacco issue

Robert Molimard   

When contaminated by pesticides such as Gaucho ® or Regent ®, a bee becomes disoriented and can no longer find its hive or its wild flowers of choice. We cannot solve a problem if the messages are muddled. Undeniably, disturbing one’s sense of orientation and muddling communication hinders rational thought and behavior. Lies and manipulations are the weapons of choice for political and economic gains without regard for the well-being of people or the survival of the planet.

Tobacco manufacturers and merchants, the state, self-righteous non-profit organizations, the pharmaceutical industry - all powerful entities involved in tobacco issues - are ready to do anything to promote their own agendas. In a curious collusion, they all seem to be quite content with a general state of public confusion in which scientific truth has no place, and where the smoker, convinced of his own guilt, has become the apathetic victim.

The Tobacco Industry

As soon as the very first findings of the risks of smoking were publicized, the tobacco industry was quick to rebut these with misleading advertising.

Although some ads promoted the relaxing effects and social advantages of smoking, and even the glamorous aspect supposedly so seductive to women, other ads, however, specifically contested the negative health effects. During the period between the two world wars, in the United States where trade was not controlled by a Board of State as in France, many tobacco advertising posters were associated with doctors. For example:

‘’More doctors smoke Camels than any other cigarette’’; in a classic “argument from authority”, the ad encouraged people to follow the example of doctors, who must certainly know best.

Or in another ad where we find the caption "Not one single case of throat irritation due to smoking Camels!" accompanied by the photo of an ENT with his stereotypical head mirror. They can’t possibly be dangerous when it is an Ear, Nose and Throat specialist who says they are not.

And your doctor will go as far as prescribing L & M filter cigarettes: ‘’Just What the Doctor ordered’’. Instead of quitting smoking, they would even suggest that you switch to Philip Morris and in 3 out of 4 cases your cough will disappear! [1]

But the greatest success story in misleading tobacco advertising is the “light cigarettes” scam. On June 8, 1985, during the 3rd day of tobacco dependence I organized in Paris at la Faculté des Saints Pères, I had invited LT Kozlowski to give us a demonstration of the work he had done in Toronto with a smoking machine [2]. He explained that the amounts of nicotine and tar displayed on cigarette packs had nothing to do with the content in the tobacco itself. Moreover, tobacco contains no tar. It is formed during the combustion process. In other words, what the outcomes actually represented was the amount collected in the smoke when the cigarette was smoked by a machine under standard conditions. As for tobacco, it was virtually the same whether the cigarette was labeled heavy or light, based on the readings obtained from the machine. The big difference was made by the micro-perforations in the filter through which ambient air from the room can enter. Consequently, when the machine sucks the standard 35ml puff, if 30 ml enters through the perforations, the dosage relates to only 5 ml of smoke! All Kozlowski had to do is block the ventilation and change the setting on the machine to see the content multiplied by 22 for the reading obtained for 0.1 mg of nicotine and by 29 for that of tar. The smoker is perfectly capable of doing exactly that. Moreover, from determination of salivary cotinine in 2031 smokers of their usual cigarette, yielding from 0.1 to 1.mg of nicotine, Martin Jarvis calculated their real nicotine intake. He did not find any difference. Nicotine intake was about the same, irrespective of the machine-yield of the cigarette they smoke. (3)

The conclusion is clear and unequivocal: The smoker is not a machine. Yields reported are of no use in predicting the absorption of toxins. And yet, 20 years later, a European directive specified that as of January 1, 2004, contents (sic) for cigarettes should not exceed 10mg per cigarette for tar, 1mg for nicotine and 10mg for carbon monoxide. This 2003 directive is still in effect! It therefore becomes compelling to conclude that the EU endorses the light cigarettes deceit. I see only two possible explanations. Either the ‘’experts’’ who advise the EU are guilty of total incompetence and gross ignorance, or else they are moles of the tobacco industry. In any case, I personally have not been consulted and therefore plead not guilty.

The Medication Enterprises (Les entreprises du médicament)

Let us first of all acknowledge the change of name. It is neither innocent nor without reason. Formerly, it was known as the Pharmaceutical Industry, which is not a very reassuring name. Industry evoked factory chimneys belching black smoke. Pharmaceutical, springs to mind images of jars labeled “Poison’’ with a skull crossed in red. Enterprises on the other hand sounds dynamic, and evokes progress. As for Medication, it serves to heal, how can that not be beneficial? Is it a matter of a simple naive case for an enhanced image or a manifestation of the art of manipulation?

The big fraud in the tobacco issue was none other than the publication of the 1988 Surgeon General Report entitled “Nicotine Addiction’’. This fraud is incomprehensible unless one sees the link with the launch of the nicotine gum. The major premise of the Report seems to be a syllogism that states: “Tobacco products cause a powerful addiction’’ The minor premise is: “Tobacco contains a neurotropic poison - nicotine’’. Hence follows the conclusion: “Therefore nicotine is responsible for the addictiveness of tobacco’’. But there is no evidence that allows us to draw such a conclusion. A host of other assumptions are possible, and there are even major arguments to oppose it, such as the fact that no cases of nicotine dependence have ever been documented when this substance was used in isolation, as was already established long before the “Medication Enterprises” began marketing nicotine as a form of medication. This duplicity is more than amazing when you consider how common it is for addicts to experiment with the purified extracts of their plants of choice. Since no formal evidence of dependence to pure nicotine has yet to be produced, the conclusion that nicotine alone is addictive is not a syllogism, but rather, pure sophistry.

And yet, against all scientific rigor, this fallacy was implanted through repetition, hammered in as an unassailable truth, all with the support of health authorities and politicians. Thus the famous Fagerström test in the AFSSAPS good practice recommendations, continues to be called ‘’test for nicotine dependence’’. Yet not one of its 6 items even refers to it. This is simply a test for cigarette dependence and we would have no objection if it were referred to as such. Is this a minor detail? No, it is clearly an intentional mistake, extremely serious in its consequences both intellectually and scientifically. Because having arbitrarily decided that nicotine alone explains tobacco dependence and having it engrained in the minds of doctors, the authorities and the public, any research on the other possible factors of this dependency is now excluded in advance and a vast new market is made available for commercial exploitation by the pharmaceutical industry.

But a second manipulation, easy to debunk at least in theory, is also currently wreaking havoc: the big lie used as the basis of all repressive policies against smokers on the basis of passive smoking. As one would expect, they found popular support from non-smokers, forceful because they are now the majority, as well as among a number of smokers who considered that it would give them the incentive they required to rid them of their cigarette dependence. It is undeniable that the omnipresence of smoke was becoming increasingly intolerable and that regulation was necessary for the sake of non-smokers who had enough of the constant annoyance. But they had to find an argument that carried greater weight than simple inconvenience to non-smokers – the danger of other people's smoke to the health of nonsmokers. In 1990, Catherine Hill, estimated the annual deaths from passive smoking for France to be 1000, of which around one hundred were lung cancers. She noted that the margin of uncertainty becomes quite wide when dealing with estimates of such low impacts. In front of the Academy of Medicine, Pr. Tubiana in 1997 applied the considerable increase in cardiovascular risk of the U.S. assessment to France and estimated the death toll from passive smoking to be 2500, including 105 lung cancers. In 2005, without producing any specific study for France, Norman and Dubois reported 3000 deaths from passive smoking.

But these increases were still not sufficient to reach the critical level that would have made second hand smoke a serious public health problem warranting drastic measures. That’s when an international report made its appearance. Produced by four institutions, Cancer Research UK, European Respiratory Society, Institut National du Cancer and the European Health Network, announced, with great precision, 5863 deaths for France, quickly rounded to 6000 deaths for the press [4]. They had finally reached the level that was required to justify the measures that were quickly adopted in most countries. (Figure 1)

(Figure1) Reproduction of the table in the report ‘’Lifting the SmokeScreen’’ assessing mortality for France by passive smoking. It is broken down by age and exposure at home or at the place of employment, indicating separately the employment in the ‘’hospitality industry’’, including hotels, restaurants, bars and nightclubs. Moreover, deaths are calculated separately for the various causes - lung cancer, cardiovascular disease, stroke and chronic respiratory diseases. None of these estimates takes into account statistical spreads.

But anyone who would had carefully read this report would have discovered that, with the utmost simplicity and dare I say nonchalance, the authors also showed separately the estimates for non-smokers thus revealing that smokers themselves were included in their total death estimates. In doing so,  they changed the definition of passive smoking itself! And suddenly, with only 1,114 deaths in non-smokers including 152 lung cancers, we almost went back to Catherine Hill’s estimate of 20 years earlier.''   When breaking down these 1114 deaths, it becomes unclear how a law banning smoking in public spaces can have any effect on 1007 of these 1114 deaths that relate to exposure at home, providing of course that the police are not permitted to break down your door with a ram to fine your smoking spouse. 107 deaths were attributed to exposure at work, and 6 of them to the special conditions for the hotels restaurants, bars and discos where the application of the ban was delayed by one year. (Figure 2)


Figure 2 .- Reproduction of the table in the report ‘’Lifting the SmokeScreen’’ assessing mortality for France by passive smoking among non-smokers. This is the only assessment that matches the traditional definition of passive smoking, ie ‘’non-smoking victims due to other people's smoke’’. The overall assessment comes from old data. The importance of exposure to the spouse’s second hand some at home is surprising, as is the weakness of death by exposure in the workplace, especially in the hospitality industry, where the consequences of the ban have had the biggest social impact.


Thus the authors have classified 4749 active smokers as victims of passive smoking using the specious argument that when smoking in their offices they also inhale the ambient air filled with their own smoke! I have previously produced a complete analysis of this outrageous report [5]. It obviously did not elicit any response. In my analysis, I pointed out that this report was presented at a conference held in Luxembourg on June 2, 2005, in the presence of the highest authorities of Europe, by the associations mandated to adopt it and under the sponsorship of GlaxoSmithKline and Pfizer precisely at the same moment as the launch of Champix ®.

But in terms of marketing, the operation is a failure. Indeed, not only have smokers, despite being stigmatized and persecuted, did not rush off to the pharmacies in response to the bans, but sales of all drugs known as ‘’nicotine replacement therapy’’ are plummeting. And this notwithstanding the intense indirect television advertising that should in fact be banned since in France it is not permitted to advertize for medication that is reimbursed by social security. One has to be blind not to see through their hardly veiled scheme that these ads make smokers aware of the drugs that are eligible for reimbursement so they can insist that their doctor prescribes those particular drugs to them.

But the major concern for anyone who really cares about the health of smokers, is that such drastic measures are counterproductive to smoking cessation. The official sales of tobacco increased while the smuggling figures do not show any reduction. The prevalence of smoking among youth is increasing. Smoking cessation consultations are increasingly abandoned by their clients. The Diplomas of Tobacology no longer attract any students. In defense of their proper identity, smokers now sink into themselves and shut themselves off in a way that public health messages [6] can no longer reach them.

The Anti-Tobacco Crusaders

These activists have abandoned logical reasoning and replaced it with faith and passion. Anything goes when it comes to pursuing the triumph of their such “good cause’’, and “white lies’ are a perfectly acceptable tool.  Any open debate and any valid scientific research is therefore precluded. We do find of course some pure idealists, survivors of former “virtuous movements’’ among them. Be that as it may, there are unfortunately a great number of self-interested do-gooder apostles fueling and exploiting to their advantage this blind militant force in an effort to assert their own power and fame, not to mention more tangible benefits.

For these knights of purity, tobacco is the absolute evil, the devil. It must be eliminated, eradicated. At the very least, it must be hidden or sold “under the counter’’, much like porn magazines (sic). The tobacco industry is diabolical. It must be destroyed, made to disappear, bankrupted through litigation.

The problem is that if the tobacco industry exists it is because it responds to a demand. If tobacco has spread around the world since Christopher Columbus, during an era when there was no other means of advertising than word of mouth and when tobacco was cultivated by primitive means, it is because there is something attractive about the product that causes people to crave for it. The industry responded to the demand, it did not create it. If the industry were to disappear, the demand would remain and would require to be fulfilled. And it would be fulfilled. Multinationals would be investing their money in tax havens, where they would fund an offshore production in some underdeveloped nation. Cigarettes would be distributed through organized criminal networks, fueling underground commerce and auxiliary crimes in the process. No quality control could ever be achieved. Control could only be dealt with through the police and corruption would inevitably creep in. For these reasons, the fundamentalist anti-tobacco crusaders are a true danger to social balance and public health.

As for the smoker, he is seen as someone possessed by the devil. He must be pursued, hunted down to his last hide-out, even in his own home. The smoker loses the ordinary rights of ownership and freedoms within his own home. Already in the U.S. smokers are increasingly denied rental housing. Moreover, in the spirit of good Judeo-Christian morality, he must be punished by where he has sinned. Let his vice cost him and ruin him. Let us therefore increase the price of cigarettes and rolling tobacco. For decades, we have been served a lie, with no tolerance for any criticism or challenge, namely: that the only effective method to reduce smoking prevalence is to increase the price of cigarettes. But since it does not work, they allege that it is because the increases are neither high enough nor frequent enough! But just as with their tactic of stigmatization of smokers, the high-price policy does not work.

That is where the real failure lies. One could always be tempted to defend such a policy if its success outweighed its serious adverse effects. Effects that destroy the individual, the HUMAN-slave to cigarettes. It sinks him into poverty and social exclusion, pushing him into more dangerous smoking behaviors. But it does not exorcise the demon of addiction.

They attempt to justify these dehumanizing policies by referring to large statistics with abstruse mathematical models [7]. However, if any of these policies were truly effective one would think that after 30 years of applying them worldwide we should be noticing their effects. Smoking prevalence should be lower in places where the prices are high. Comparing the 27 countries of the European Union for smoking prevalence according to price, and after adjusting for purchasing power, we should be able to calculate a significant regression line with a nice negative slope. I drafted this graph based on 2009 [8,9] data. The result is not debatable. We observe a cloud of dots, there is no significant correlation, and to add mockery to injury, the calculated regression line shows a positive slope! (Figure 3)

Figure 3 – Distribution of smoking prevalence in the EU in 2009 according to the price of the most popular brand of cigarettes (Marlboro ® ) adjusted for purchasing power. 


Science can only progress if we learn from its mistakes. What is truly diabolical is keeping our eyes tightly shut and manufacturing the results to best serve our own interests and obsessions!


References

1.- The University of Stanford website contains an important collection of cigarette advertizing images that can be downloaded from http://lane.stanford.edu/tobacco/index.html

2.- Kozlowski LT, Rickert WS, Popo MA, Robinson JC. Estimating the yields to smokers of tar, nicotine and carbon monoxide from the "lowest-yield" ventilated-filter cigarettes. Br. J. Addict. 1982b, 77 : 159-65

3.- Jarvis MJ, Boreham R, Primatesta P, Feyerabend C, Bryant A. Nicotine yield from machine-smoked cigarettes and nicotine intakes in smokers: evidence from a representative population survey .J Natl Cancer Inst. 2001 Jan 17;93(2):134-8.

4.- Lifting the smokescreen, 10 reasons for a smokefree Europe .www.ersnet.org

5.- Molimard R. Le rapport européen "Lifting the smokescreen: Etude épidémiologique, ou manipulation? Revue d'Epidémiologie et de Santé Publique, (2008) 56 ;(n°4): 286-90

6.- Falomir, J. M., Mugny, G. (2004) Société contre fumeur, Une analyse psychologique de l’influence des experts. Grenoble : Presses Universitaires de Grenoble

7.- Ross H, Blecher E, Yan L, Hyland A. Do cigarette prices motivate smokers to quit? New evidence from the ITC survey. Addiction. 2010 Nov 9. doi: 10.1111/j.1360-0443.2010.03192.x. [Epub ahead of print]


9.- The 2009 prices of a pack of 20 Marlboro cigarettes in 27 countries of the EU adjusted for purchasing power, according to http://www.cancer.be/images/journaliste/Communique-de-presse-taxation-tabac-100929.pdf

Wednesday, 17 November 2010

IS THE ANTI-TOBACCO INDUSTRY'S OUTRAGE JUSTIFIED?

There is much ado these days in the anti-smoker industry about the Federal Government’s decision to suspend the plan for new health warnings on cigarette packages. The outrage of the various anti-tobacco industry representatives has been largely covered by all major newspapers in Canada. The general public’s opinion leans more in favor of the government’s decision than the anti-smokers groups, if we judge by the comments of the posters in the different newspaper forums. Most commentators feel that wasting money on new health warnings when those present already cover 50% of the packages and are plenty explicit, is not a good idea. Keeping in mind that since it is the consumers who already absorbed the millions it cost for the research of these labels and who will ultimately absorb the costs of the tobacco industry’s obligation to change the packages, many are asking for proof that they will work before further millions, public or private, are injected in what they feel is only another piece of useless “straw-man” legislation.

The core argument of the anti-tobacco groups is that from a leader in anti-tobacco policies, Canada has now fallen to 15th when it comes to health warnings. This can easily bring to mind images of some sort of nanny-state Olympics or anti-smoker Oscar Night celebration. Indeed there is just such an awards event: From page 10 of the Report of The Framework Convention Alliance.

The Bulletin also served as the podium for the daily conferring of the Orchid and Dirty Ashtray awards. The former award recognized individual or group of Parties that have made considerable strides in implementing the WHO FCTC since its conception, commendable country position, and/or playing a constructive role during the talks; while the Dirty Ashtray denounced those that played a negative role throughout the negotiations, or failed to meet the obligations of the WHO FCTC.

Never mind if the Canadian society cannot bare further regulation without indignation and revolt, oh the embarrassment if from one time “Orchid Award” winners our Canadian do-gooders ever get the much dreaded “Dirty Ashtray Award” !

For the highly paid anti-smokers who tour the world with our tax money to want to be champions in some global zealot competition, it is par for the course in conducting business to survive in the competitive market of anti-smoking activism. Governments are now slashing the anti-tobacco funding and our do-gooders are desperately struggling to gain back what they consider to be due to them. In our opinion, wanting to be 1st in anti-tobacco activism, is their way of standing out in their pursuit for more grants that will secure them another couple of years of prosperity at our expense in a society that has just about had enough of these insatiable do-gooders.

We are especially surprised that the Canadian Medical Association (CMA) has actively pronounced itself in favour of the new health warnings. It is puzzling and alarming that the CMA finds it appropriate to condone the anti-smokers’ outrage and criticize the federal government who seem to be resolved to not give in to the pressure tactics currently being exerted. Perhaps the good doctors and representatives of the CMA have failed to take any notice of this article from one of their American peers, Health Agencies Boast of Dramatic Impact of New Cigarette Warning Labels

Excerpts:

Smokers are already aware of the harmful consequences of smoking and lack of knowledge of the health effects is not a significant factor in explaining why millions of Americans continue to smoke or why youths begin smoking. Research shows that warning labels have a limited impact on smoking behavior.

The real threat to the tobacco industry would have come from eliminating the warning labels on the packs, and thus opening up the companies to devastating lawsuits. Congress chose the weaker approach of requiring mildly stronger warning labels but completely immunizing the tobacco companies from any prospect of serious financial damage in future litigation.

And perhaps part of the answer for the CMA’s position can be found in the following article:

Excerpts:

(Pfizer) is currently on a very aggressive campaign to do more than sell drugs. It is staking out new territory and investing in innovative ways to influence the people who make decisions about healthcare.''
''it (Pfizer) has also established a new “partnership” with the Canadian Medical Association, which represents Canada’s 70,000 doctors who were recently on the receiving end of $780,000 new Pfizer dollars to help educate our physicians.''

We remind our readers that Pfizer just happens to be the maker of Champix and nicotine replacement therapies. Pfizer has a vested economic interest in this matter, and the actions of the anti-tobacco industry appear to be serving those economic interests.

The concept of “doing good” and turning a profit at the same time is one that we can accept in theory, as long as the “good” is being done in an honest, transparent and evidence-based manner. The anti-tobacco industry and the pharmaceutical industry appear very closely linked, and their consistent collaboration with one another is cause for concern. The position of the anti-tobacco industry with respect to the health warnings appears to be far more helpful to the pharmaceutical industry than to the people at large. The general public in this case are correct to follow their instinct and disbelieve the propaganda campaign of the anti-smoking industry and its financial supporters.

One of the most vocal groups against the US health warnings that are also making the news, is one of the largest e-cigarette communities, aka vapers, who are now standing tall beside smokers and their fight for truth, justice and evidence-based policy. They are now seeing clearly that the war against tobacco has turned into an ugly, out-of-control war against smokers and not only do they sympathize with the smokers in a compassionate way, but they are realizing that nothing will stop the zealots in their fight to eliminate electronic cigarettes on absolutely no evidence of harm to either the vapers or the bystanders. We are delighted to have their support on this particular issue.

Logic dictates that if the anti-tobacco industry were primarily concerned by the well-being of the people, they would abandon the wasteful campaign for additional health warnings and actively support truly effective alternatives to smoking, such as the e-cigarettes.

Monday, 22 March 2010

LE TABAGISME EN HAUSSE EN FRANCE


À l’instar d'un nombre de pays qui ont vu leur taux de tabagisme augmenter depuis les lois anti-tabac répressives, la France a connu une hausse du nombre de cigarettes consommées ce qui est en soi un échec pitoyable de la part des anti-tabagistes. Non seulement ont-ils bouleversé les mœurs et l’économie mais ils ont dépensé des millions en fonds publics pour des lois vouées à l’échec dès le départ. Ce n’est pas comme si nous ne les avions pas prévenus!


La bonne nouvelle cependant est que les français ont massivement arrêté de croire aux produits pharmaceutiques presque complètement inefficaces pour l’arrêt du tabac. En effet les ventes pour ces produits ont diminué de 46% pour les patchs et de 29% pour le Champix, médicament déclaré dangereux par les autorités sanitaires tel que la FDA. Il ne reste plus qu’à espérer que les pharmas cessent de promouvoir ces produits, sous le mensonger prétexte qu’ils fonctionnent, pour que l’on puisse sagement retourner aux bonnes méthodes qui ont fait leurs preuves en ce qui a trait à l’arrêt du tabac, soit l’éducation et la force de la volonté des gens.

Monday, 4 January 2010

RIGUEUR JOURNALISTIQUE NULLE POUR CANOE.CA


Pourquoi se contenter d’utiliser un seul produit pharmaceutique à la fois pour arrêter de fumer quand on peut se procurer de deux ou trois ? C’est ce que certains chercheurs proposent.

Remarquez que dans cette étude (lien plus bas), qui nous provient de l’Université du Wisconsin, on parle des pourcentages de succès d’arrêt tabagique sur une période de six mois sans aucune mention du pourcentage de succès à long terme. Pas surprenant lorsqu’on sait que,
selon certaines études, les produits pharmaceutiques ne sont efficaces que pour 1,6% des cas sur le long terme !

Aucune mention non plus dans cet article de Canöe à l’effet que cette étude fut financée par la compagnie pharmaceutique Glaxo Smith Klein et que cette dernière a fournit les médicaments dont on s’est servit pour l’étude !’The medication was provided by GlaxoSmithKline. Several authors reported financial relationships with the pharmaceutical industry.’’

Tous ceux qui nous lisent régulièrement ont probablement déjà pris connaissance de notre article en anglais qui nous provient d’un activiste anti-tabac, John Polito, qui dénonce les conflits d’intérêts flagrants entre l’industrie anti-tabac et l’industrie pharmaceutique. Vous le trouverez ici.

Disons- le clairement : Les études sérieuses et non biaisées démontrent que quiconque désire vraiment arrêter de fumer, y parvient sans aucune assistance pharmaceutique. Alors la prochaine fois que les médias francophones vous servent des tels articles dénués de toute rigueur journalistique, n’hésitez pas de les questionner sur la raison qui les motivent de ne pas inclure les provenances des fonds pour des telles études et pourquoi ils ne font pas l’effort de faire un peu de recherche afin de nous présenter les faits au lieu de servir de vitrine pour la vente des produits non seulement dispendieux mais presque totalement inefficaces.

Une combinaison de thérapie pour arrêter de fumer

Monday, 21 September 2009

HOW LONG WILL THIS BILLION DOLLAR CHARADE CONTINUE? - John R. Polito

With Mr. John Polito’s, - a well known advocate of cold turkey tobacco cessation - explicit permission, we are posting here his comment on how far the pharmaceutical industry has corrupted the tobacco issue, more particularly the cessation methods. His passionate comment is rich with links you can follow that illustrate precisely his point. Mr. Polito has advised us that anything he publishes on the web is public domain, so please feel free to spread it far and wide. Politicians must be made to feel that we have had enough of allowing Big Pharma to operate without any accountability for the damage they are causing individuals and society through their unethical, immoral and fraudulent marketing tactics for economic gain.

As posted in Dr. Siegel’s blog at: http://www.haloscan.com/comments/mbsiegel/8151429188389081481/

Dr. Siegel, thanks for helping expose the greatest research sham in pharmaceutical industry history. The ALF, ALA, ACS, RWJF, CDC, AHRQ, DHHS, GSK & Pfizer all are aware that they have been active participants in scamming smokers into believing that quitting without pharmacology is nearly impossible, when in fact that's how 9 out of 10 long-term ex-smokers succeed. It's a false and deceptive campaign done solely for economic gain.

By the way, Professor Simon Chapman, Australia's leading tobacco control voice, just released an attack upon Pfizer (entitled: "Pfizer's campaign to drug as many smokers as possible") that sounds an awful lot like something Dr. Siegel might say:
http://www.crikey.com.au/2009/09...rs-as-possible/

The bottom line is that all of these organizations are by now fully aware that it's impossible to blind smokers with significant quitting histories as to the onset of full-blown withdrawal. As a study by the nicotine patch co-inventor (Jed Rose of Duke) just found, four times as many placebo nicotine patch users were able to correctly identify their group assignment as were wrong about it. More than 200 placebo controlled cessation trials have measured levels of frustration not efficacy. What's sad is how all of the above organizations insist on ignoring all real-world findings showing that real cold turkey quitters have yet to be beaten by any form of pharmacology and it's consumer fraud of the worst sort to suggest otherwise. Many of these quitters are fighting to save their lives and what do we do, we lie to them!!!!!!! God, help us!!!!!

Placebo use in drug addiction studies is a license to steal. Participants in these studies were not expecting to go cold turkey and endure full-blown withdrawal. Instead, they joined in hopes of obtaining weeks or months of a free chemical ("medicine") that would stimulate their dopamine pathways, thus diminishing their withdrawal syndrome. If assigned to placebo it didn't happen. Often 80-90% of the placebo group relapsed within the first few days. It isn't that they necessarily relapsed because they couldn't quit but because this particular effort failed to live up to expectations. The results aren't science. They're junk.

How much longer will this billion dollar charade continue? President Obama promised that science would be driven by facts not profits. When, Mr. President?

Thanks for focusing on the ALF's pharmacology sales site, www.BecomeAnEx.org, Dr. Siegel. Dr. Richard Hurt's name, face and advice are all over the BecomeAnEx site. But as disclosed in this 2009 paper, he also serves on Pfizer's Advisory Board -
http://caonline.amcancersoc.org/...ct/ caac.20031v1

In this video clip Dr. Hurt crams pharmacology down the viewers throats by falsely asserting that pharmacology doubles "your" chances. Dr. Hurt knows that that is a real-world effectiveness representation he's making there, not a clinical trial placebo efficacy claim -

http://www.becomeanex.org/the-ex...arn_addiction/ 2

Here's a second clip claiming medicine can double "your" chance of success (at tail end) - again, it's a clearly false effectiveness claim -
http://www.becomeanex.org/the-ex...earn_overview/ 3

Here Dr. Hurt explains how to pick the right pharmacology -
http://www.becomeanex.org/the-ex...arn_addiction/ 3

In this ALF video Dr. Hurt teaches how to chew nicotine gum -
http://www.becomeanex.org/the-ex...arn_addiction/ 4

Here the ALF's drug store teaches about the nicotine lozenge -
http://www.becomeanex.org/the-ex...arn_addiction/ 5

This is Dr. Hurt selling the nicotine patch -
http://www.becomeanex.org/the-ex...arn_addiction/ 6

This is his nicotine inhaler clip -
http://www.becomeanex.org/the-ex...arn_addiction/ 7

This is his nicotine spray clip -
http://www.becomeanex.org/the-ex...arn_addiction/ 8

This is his Zyban and Chantix clip. Amazingly he does not advise viewers of any adverse event or death concerns associated with using Chantix. As a member of Pfizer's Advisory Board, how does he get away with it?

http://www.becomeanex.org/the-ex...arn_addiction/ 9

In this clip he again encourages quitters to talk with their physician about medications. If using an OTC product, why would they also need to make an appointment to see their doctor?
http://www.becomeanex.org/the-ex...rn_addiction/ 10

This clip is about getting medication and setting a quit date. The problem with the ALF's advice is that we now have two studies asserting that not setting a quit date, that quitting spontaneously, doubles your chances. These are the study links:

http://www.ncbi.nlm.nih.gov/pubm...pubmed/ 16443610

http://www.ncbi.nlm.nih.gov/pubm...pubmed/ 19509277

So which is it ALF? Get visitors to buy medicine and pick a quit date or advise them to jump in the quitting pool without meds? This advice should be immediately corrected. If not, it's a rather glaring admission that ALF's quitting site is nothing more than a pharmaceutical industry drug store.
http://www.becomeanex.org/the-ex...#being_ex/ share

Overall, a fair assessment of the ALF's quitting site would be that it strongly suggest that quitting without medication is far less successful than quitting with it.

Did the ALF read the National Cancer Institute's quitting method survey showing non-pharmacology quitters actually doing better? How about the long-term results from the UK's NHS Stop Smoking Program? Do you care about "truth" or is that simply some job security slogan to tag tobacco companies with?

I used to think cessation pharmacology researchers were simply misguided but it has been way too many years and there's now far too much evidence for them to continue to claim ignorance. I hate to say this but I now believe that most are either amazingly stupid or criminally culpable in the deaths of untold thousands of pharmacology scammed smokers, who trusted the fancy credentials and lies into their grave. It's Dr. Drug Rep all over. It's pretty sad that history will record that money was more important than their legacy.

By the way, I see the word "quitting" getting bantered about when discussing the e-cig. Until the pharm industry extracted nicotine from the tobacco plant all quitting involved both quitting nicotine and its delivery device. For the sake of accuracy and both youth and user understanding I'd encourage use of the word "transfer" instead of "quitting" as delivery continues.

Regards,